Giving the GLP-1 analogue ROSE-010 to a mixed group of IBS patients decreased GI motility and relieved acute discomfort, according to a placebo-controlled double-blind crossover clinical experiment (24). This evidence concerns the gene GCG and irritable bowel syndrome.